Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction

被引：177

作者：

Ma, J ^{[1
]}

Ge, JB ^{[1
]}

Zhang, SH ^{[1
]}

Sun, AJ ^{[1
]}

Shen, JY ^{[1
]}

Chen, LL ^{[1
]}

Wang, KQ ^{[1
]}

Zou, YZ ^{[1
]}

机构：

[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200032, Peoples R China

来源：

BASIC RESEARCH IN CARDIOLOGY | 2005年 / 100卷 / 03期

关键词：

stromal cell-derived factor-1; homing; stem cell transplantation; cardiac function;

D O I：

10.1007/s00395-005-0521-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective The chemokine stromal cell-derived factor-1 (SDF-1) has been implicated in homing of bone marrow cells to sites of injury. We investigated the time course of myocardial SDF-1 expression and effects of intravenously administered bone marrow mesenchymal stem cells ( MSC) in rats with myocardial infarction (MI). Methods SDF-1 expression was measured by RT-PCR and Western blot in sham operated or infarcted hearts at 1/2, 1, 2, 4, 8 and 16 days post operation. MSCs from donor rats were labeled with BrdU. A total of 5 x 10(6) cells in 2.5 mL of PBS or equal volume PBS alone were injected through the tail vein at above mentioned time points. The number of the labeled MSCs in the infarcted hearts was counted 3 days post injection. Cardiac function and vessel numbers were assessed 28 days post injection. Results Myocardial SDF-1 expression increased and peaked at the first day and decreased thereafter post MI and remained unchanged in sham operated hearts. The MSCs enrichment and angiogenesis in the host hearts were more abundant in the 1 day transplantation group than in the other groups ( P < 0.01). Cardiac function was only improved in rats received intravenous MSCs injection within 4 days post MI and not affected by PBS injection. Conclusions Myocardial SDF-1 expression was increased only in the early phase post MI. MSCs intravenous infused at the early phase of MI were recruited to injured heart, enhanced angiogenesis and improved cardiac function.

引用

页码：217 / 223

页数：7

共 18 条

[1] Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling [J].

Aicher, A ;

Brenner, W ;

Zuhayra, M ;

Badorff, C ;

Massoudi, S ;

Assmus, B ;

Eckey, T ;

Henze, E ;

Zeiher, AM ;

Dimmeler, S .

CIRCULATION, 2003, 107 (16) :2134-2139

[2] Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].

Askari, AT ;

Unzek, S ;

Popovic, ZB ;

Goldman, CK ;

Forudi, F ;

Kiedrowski, M ;

Rovner, A ;

Ellis, SG ;

Thomas, JD ;

DiCorleto, PE ;

Topol, EJ ;

Penn, MS .

LANCET, 2003, 362 (9385) :697-703

[3] Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].

Barbash, IM ;

Chouraqui, P ;

Baron, J ;

Feinberg, MS ;

Etzion, S ;

Tessone, A ;

Miller, L ;

Guetta, E ;

Zipori, D ;

Kedes, LH ;

Kloner, RA ;

Leor, J .

CIRCULATION, 2003, 108 (07) :863-868

[4] Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].

Campagnoli, C ;

Roberts, IAG ;

Kumar, S ;

Bennett, PR ;

Bellantuono, I ;

Fisk, NM .

BLOOD, 2001, 98 (08) :2396-2402

[5]

GARCIA RL, 1989, AM J PATHOL, V134, P733

[6] Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells [J].

Hattori, K ;

Heissig, B ;

Tashiro, K ;

Honjo, T ;

Tateno, M ;

Shieh, JH ;

Hackett, NR ;

Quitoriano, MS ;

Crystal, RG ;

Rafii, S ;

Moore, MAS .

BLOOD, 2001, 97 (11) :3354-3360

[7] Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor [J].

Hiasa, K ;

Egashira, K ;

Kitamoto, S ;

Ishibashi, M ;

Inoue, S ;

Ni, WH ;

Zhao, QW ;

Nagata, S ;

Katoh, M ;

Sata, M ;

Takeshita, A .

BASIC RESEARCH IN CARDIOLOGY, 2004, 99 (03) :165-172

[8] Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines [J].

Kamihata, H ;

Matsubara, H ;

Nishiue, T ;

Fujiyama, S ;

Tsutsumi, Y ;

Ozono, R ;

Masaki, H ;

Mori, Y ;

Iba, O ;

Tateishi, E ;

Kosaki, A ;

Shintani, S ;

Murohara, T ;

Imaizumi, T ;

Iwasaka, T .

CIRCULATION, 2001, 104 (09) :1046-1052

[9] Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function [J].

Kocher, AA ;

Schuster, MD ;

Szabolcs, MJ ;

Takuma, S ;

Burkhoff, D ;

Wang, J ;

Homma, S ;

Edwards, NM ;

Itescu, S .

NATURE MEDICINE, 2001, 7 (04) :430-436

[10] SERIAL ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR GEOMETRY AND FUNCTION AFTER LARGE MYOCARDIAL-INFARCTION IN THE RAT [J].

LITWIN, SE ;

KATZ, SE ;

MORGAN, JP ;

DOUGLAS, PS .

CIRCULATION, 1994, 89 (01) :345-354

← 1 2 →